Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30290953.
- Also identified by DOI 10.1016/j.chest.2018.03.048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Idiopathic pulmonary fibrosis is the most common idiopathic interstitial pneumonia. Prognosis is poor with a median survival <3 years. Pirfenidone is one of two US Food and Drug Administration-approved medications that slow disease progression. We describe the development of lymphadenopathy or a sarcoid-like reaction following initiation of pirfenidone, a complication not previously reported.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Idiopathic Pulmonary Fibrosis
- Pyridones
- Sarcoidosis, Pulmonary